Business description: PCAS
- synthesized pharmaceutical products (63.5%);
- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).
At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.
France accounts for 76% of net sales.
Number of employees: 1,178
Sales by Activity: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
Pharmaceutical Synthesis | 128M | 135M | 120M | 144M |
Fine Speciality Chemicals | 73.25M | 58.92M | 67.41M | 82.72M |
Geographical breakdown of sales: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
France | 163M | 155M | 143M | 172M |
Other Areas | 38.01M | 38.92M | 44.36M | 54.3M |
Executive Committee: PCAS
| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 03/05/2025 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/1999 |
Composition of the Board of Directors: PCAS
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 01/03/2014 | |
Janine Cossy
BRD | Director/Board Member | - | - |
Company details: PCAS
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.30% | -1.01% | +44.50% | +136.21% | 1,206B | |
| +1.37% | +3.34% | +48.40% | +89.66% | 665B | |
| +0.34% | +1.13% | +33.56% | +111.61% | 515B | |
| +2.77% | +0.98% | +43.81% | +68.46% | 381B | |
| +0.46% | -0.60% | +69.99% | +44.04% | 362B | |
| +0.29% | +1.48% | +30.59% | +58.32% | 307B | |
| +0.98% | +1.49% | +7.16% | +34.78% | 289B | |
| +0.50% | -0.39% | +43.25% | +75.59% | 249B | |
| +1.07% | -0.92% | +42.83% | +125.07% | 207B | |
| Average | +1.10% | -1.54% | +40.46% | +82.64% | 464.42B | |
| Weighted average by Cap. | +1.58% | -1.96% | +42.16% | +94.74% |
